Year archive

SYNTARA LIMITED — 2013 filings

All 70 regulatory filings released by SYNTARA LIMITED (SNT) in 2013, sourced directly from the official regulator.

70 Filings

2013 Period

2013 filings (70)

Filing	Released	Lang
Appendix 3B - Exercise of employee options 11 pages 90.4KB Share Issue/Capital Change	2013-12-11	English
Scottish Medicines Consortium Accepts Bronchitol for CF Use 2 pages 115.6KB Regulatory Filings	2013-12-09	English
Change of Director's Interest Notice 2 pages 73.5KB Director's Dealing	2013-12-01	English
Results of Meeting 2 pages 83.7KB Declaration of Voting Results & Voting Rights Announcements	2013-11-27	English
Appendix 3B 12 pages 97.0KB Share Issue/Capital Change	2013-11-27	English
Chairman's Address to Shareholders 3 pages 118.3KB AGM Information	2013-11-26	English
CEO Presentation to AGM 30 pages 745.6KB AGM Information	2013-11-26	English
Appendix 3B - Employee restricted shares and options 11 pages 95.2KB Share Issue/Capital Change	2013-11-03	English
Appendix 3B - option exercise 11 pages 90.3KB Share Issue/Capital Change	2013-11-03	English
Change of Director's Interest Notice 2 pages 73.2KB Director's Dealing	2013-11-03	English
Pharmaxis Elects to Receive Full NovaQuest Investment 2 pages 113.3KB Capital/Financing Update	2013-10-29	English
Change in substantial holding 5 pages 72.7KB Major Shareholding Notification	2013-10-22	English
Change in substantial holding 5 pages 66.4KB Major Shareholding Notification	2013-10-21	English
Notice of Annual General Meeting/Proxy Form 10 pages 539.7KB AGM Information	2013-10-20	English
Appendix 4C - quarterly 5 pages 105.3KB Interim / Quarterly Report	2013-10-15	English
Pharmaxis Quarterly Investor Briefing 27 pages 343.9KB Interim / Quarterly Report	2013-10-15	English
PHARMAXIS QUARTERLY INVESTOR CONFERENCE CALL 1 page Call Transcript	2013-10-14	English
2013 Annual Report to Shareholders 91 pages 570.8KB Annual Report	2013-09-24	English
Pharmaxis Announces Two Board Retirements 2 pages 106.4KB Board/Management Information	2013-09-18	English
Final Director's Interest Notice - J Villiger 2 pages 11.7KB Director's Dealing	2013-09-18	English
Final Director's Interest Notice - R van den Broek 2 pages 11.6KB Director's Dealing	2013-09-18	English
Pharmaxis Announces Delay to French Pricing for Bronchitol 1 Regulatory Filings	2013-08-28	English
Preliminary Final Report 49 pages 414.8KB Annual Report	2013-08-14	English
Change in substantial holding 5 pages 64.9KB Major Shareholding Notification	2013-07-31	English
Appendix 3B - Exercise of employee options 11 pages 90.5KB Share Issue/Capital Change	2013-07-28	English
PHARMAXIS ANNOUNCES IMPROVED PBS LISTING OF BRONCHITOL 2 pages 112.9KB Capital/Financing Update	2013-07-17	English
Investor Presentation - Quarterly Briefing June 2013 25 pages 419.9KB Interim / Quarterly Report	2013-07-16	English
Appendix 4C - quarterly 5 pages 105.5KB Interim / Quarterly Report	2013-07-16	English
PHARMAXIS QUARTERLY INVESTOR CONFERENCE CALL 1 page Call Transcript	2013-07-15	English
Pharmaxis Awarded Two ARC Linkage Grants 2 pages 130.2KB Regulatory Filings	2013-07-04	English
European CF Clinical Trial in Paediatric Patients Begins 2 pages 131.2KB Regulatory Filings	2013-06-19	English
Pharmaxis Presents New Analyses of Pooled CF Data at EU Meet 2 pages 128.6KB Regulatory Filings	2013-06-17	English
CEO Remuneration and Employee Performance Rights 2 pages 130.3KB Remuneration Information	2013-06-06	English
App 3B - Grant of employee Options 12 pages 96.2KB Share Issue/Capital Change	2013-06-06	English
Aridol FDA Import Restrictions 1 page 119.5KB Regulatory Filings	2013-06-02	English
Outcome of Business Review 3 pages 141.9KB Capital/Financing Update	2013-05-27	English
Investor Presentation - Business Plan 21 pages 840.8KB Investor Presentation	2013-05-27	English
Investor Conference Call - Results of Business Plan 1 Call Transcript	2013-05-22	English
Pharmaxis Appoints Bronchitol Distributor for Poland 2 pages 113.4KB Regulatory Filings	2013-05-21	English
Pharmaxis Agrees Key Cystic Fibrosis Trial Paramaters with F 2 pages 164.1KB Regulatory Filings	2013-05-20	English
Ceasing to be a substantial holder 1 page 51.9KB Major Shareholding Notification	2013-05-19	English
Ceasing to be a substantial holder 1 page 51.9KB Major Shareholding Notification	2013-05-16	English
FDA Meeting, Business Review Announcement End of May 2 pages 125.4KB Regulatory Filings	2013-05-13	English
Becoming a substantial holder 4 pages 61.3KB Major Shareholding Notification	2013-05-05	English
Change of Director's Interest Notice 2 pages 74.1KB Director's Dealing	2013-05-02	English
Ceasing to be a substantial holder 2 pages 21.7KB Regulatory Filings	2013-04-28	English
PHASE 3 CLINICAL TRIAL IN BRONCHIECTASIS (B305) 3 pages 113.8KB Regulatory Filings	2013-04-23	English
Investor presentation - B305 7 pages 232.6KB Regulatory Filings	2013-04-23	English
Pharmaxis Conference Call 1 page 23.2KB Call Transcript	2013-04-22	English
Trading Halt 2 pages 56.6KB Regulatory Filings	2013-04-21	English
Change in substantial holding 2 pages 16.1KB Major Shareholding Notification	2013-04-14	English
Quarterly Investor Conference Call 1 page 23.1KB Call Transcript	2013-04-09	English
Pharmaxis Announces Bronchitol Distributor for Brazil 2 pages 86.8KB Regulatory Filings	2013-04-09	English
Investor Presentation - April 2013 21 pages 1.1MB Interim / Quarterly Report	2013-04-09	English
Appendix 4C - quarterly 5 pages 113.1KB Interim / Quarterly Report	2013-04-09	English
Change of Director's Interest Notice 2 pages 74.7KB Director's Dealing	2013-04-01	English
Trading Halt 2 pages 56.7KB Regulatory Filings	2013-03-18	English
PHARMAXIS RECEIVES COMPLETE RESPONSE LETTER FROM FDA 2 pages 107.4KB Regulatory Filings	2013-03-18	English
Pharmaxis Appoints Gary Phillips New Chief Executive Officer 3 pages 118.8KB Board/Management Information	2013-03-11	English
Final Director's Interest Notice 2 pages 12.8KB Director's Dealing	2013-03-11	English
Initial Director's Interest Notice 2 pages 68.7KB Director's Dealing	2013-03-11	English
Bronchiectasis Phase 3 Trial Milestone 2 pages 97.4KB Capital/Financing Update	2013-03-07	English
Half Year Report and Accounts 20 pages 224.1KB Interim / Quarterly Report	2013-02-14	English
Becoming a substantial holder 3 pages 583.7KB Major Shareholding Notification	2013-02-03	English
Pharmaxis Receives Negative Recommendation from PADAC 2 pages 118.7KB Regulatory Filings	2013-01-30	English
Pharmaxis Announces US$40 million Financing Areement 2 pages 88.4KB Capital/Financing Update	2013-01-30	English
Trading Halt 2 pages 57.8KB Regulatory Filings	2013-01-28	English
Appendix 4C - quarterly 5 pages 112.8KB Interim / Quarterly Report	2013-01-22	English
December 2012 Quarterly Report to Shareholders 8 pages 266.5KB Interim / Quarterly Report	2013-01-22	English
Investor Conference Call and Quarterly Report 1 pag Investor Presentation	2013-01-21	English

Filings by year

2026 36 filings
2025 88 filings
2024 101 filings
2023 72 filings
2022 95 filings
2021 96 filings
2020 65 filings
2019 48 filings
2018 69 filings
2017 53 filings
2016 43 filings
2015 58 filings
2014 33 filings
2013 70 filings
2012 71 filings
2011 90 filings
2010 77 filings
2009 74 filings
2008 67 filings
2007 85 filings
2006 82 filings
2005 79 filings
2004 55 filings
2003 11 filings